First-in-Human Single and Multiple Dose of GLPG1972
Clinical trial NCT02612246 · COMPLETED
Trial details
- NCT number
- NCT02612246
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-04-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.